Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD
Abstract Background Gastroesophageal reflux disease (GERD) has been suggested as a risk factor for acute exacerbation of chronic obstructive pulmonary disease (COPD). However, it remains undetermined whether proton pump inhibitor (PPI) treatment reduces the risk of exacerbation or affects the risk o...
Main Authors: | Jieun Kang, Rugyeom Lee, Sei Won Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-023-02345-1 |
Similar Items
-
Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
by: Reidar Fossmark, et al.
Published: (2023-09-01) -
Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
by: Byungkyu Ahn, et al.
Published: (2016-07-01) -
ESTIMATION OF CLINICAL AND PHARMACOECONOMIC EFFICIENCY OF PROTON PUMP INHIBITORS DURING GASTROESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT
by: N. E. Shabanova, et al.
Published: (2018-12-01) -
Gastroesophageal Reflux Disease: diagnosis and treatment
by: Michał Zdybel, et al.
Published: (2023-05-01) -
Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor
by: A. López-Colombo, et al.
Published: (2017-04-01)